Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 29584546

Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2018 May 10
First author
Armand P

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2018 Jul;15(7):402. doi: 10.1038/s41571-018-0022-2.
    note
    Source null
    related pmid
    29670243
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2018 Sep 10;36(26):2748. doi: 10.1200/JCO.2018.79.3547.
    note
    Source null
    related pmid
    31329709
    relationship
    Erratum in

Authors and identifiers

  1. name
    Armand P
    type
    Author
  2. name
    Engert A
    type
    Author
  3. name
    Younes A
    type
    Author
  4. name
    Fanale M
    type
    Author
  5. name
    Santoro A
    type
    Author
  6. name
    Zinzani PL
    type
    Author
  7. name
    Timmerman JM
    type
    Author
  8. name
    Collins GP
    type
    Author
  9. name
    Ramchandren R
    type
    Author
  10. name
    Cohen JB
    type
    Author
  11. name
    De Boer JP
    type
    Author
  12. name
    Kuruvilla J
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Armand P
    type
    Author
  2. name
    Engert A
    type
    Author
  3. name
    Younes A
    type
    Author
  4. name
    Fanale M
    type
    Author
  5. name
    Santoro A
    type
    Author
  6. name
    Zinzani PL
    type
    Author
  7. name
    Timmerman JM
    type
    Author
  8. name
    Collins GP
    type
    Author
  9. name
    Ramchandren R
    type
    Author
  10. name
    Cohen JB
    type
    Author
  11. name
    De Boer JP
    type
    Author
  12. name
    Kuruvilla J
    type
    Author
bibliography ids
  1. nci-bib-e5a0ea5d2ed5dd0ce448ee5b
book metadata
content sha256
49bfb54319e05e5e28e53b2b0819da378caa60317fced1c43064b5eb5ab4a6f7
document type
citation
dois
  1. 10.1200/JCO.2017.76.0793
electronic publication date
display
2018 Mar 27
precision
day
year
2018
evidence scope
bibliographic_metadata_only
id
pubmed:29584546
immutable id
pubmed:29584546@49bfb54319e05e5e28e53b2b0819da378caa60317fced1c43064b5eb5ab4a6f7
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
14
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
1428-1439
volume
36
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2018 Jul;15(7):402. doi: 10.1038/s41571-018-0022-2.
    note
    Source null
    related pmid
    29670243
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2018 Sep 10;36(26):2748. doi: 10.1200/JCO.2018.79.3547.
    note
    Source null
    related pmid
    31329709
    relationship
    Erratum in
outcomes validated
false
pmid
29584546
provenance
batch id
ec9444d0f4cade22eb9f
provider
NCBI PubMed ESummary
record sha256
29f8432343fc215383f0d7fed78d806426dbc08239650cd9757b73d9aa8223eb
response sha256
6eef0d8cc09b77e73af656f6390cc734befb84fbc4c229b886e81e5d95bece31
retrieved at
2026-09-09T23:47:30.975610+00:00
publication date
display
2018 May 10
precision
day
year
2018
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Research Support, N.I.H., Extramural
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29584546/
title
Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial.

Preserved source evidence · Not medical advice